Trademark: 88401759
Status Date
Monday, May 29, 2023
Filing Date
Thursday, April 25, 2019
Published for Opposition
Tuesday, March 3, 2020
Abandoned Date
Monday, May 29, 2023
5 Pharmaceuticals and pharmaceutical preparations, namely, Anti-infectives, anti-inflammatories, antibacterial pharmaceuticals, antibiotics, antifungal preparations, antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma; pharmaceutical preparations and pharmaceutical agents for the treatment of Wilson's disease
May 30, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
May 29, 2023
Abandonment - No Use Statement Filed
Nov 3, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 2, 2022
Sou Extension 5 Granted
Oct 25, 2022
Sou Extension 5 Filed
Nov 2, 2022
Case Assigned To Intent To Use Paralegal
Oct 25, 2022
Teas Extension Received
Apr 23, 2022
Notice Of Approval Of Extension Request E-Mailed
Apr 21, 2022
Sou Extension 4 Granted
Apr 21, 2022
Sou Extension 4 Filed
Apr 21, 2022
Teas Extension Received
Oct 23, 2021
Notice Of Approval Of Extension Request E-Mailed
Oct 21, 2021
Sou Extension 3 Granted
Oct 21, 2021
Sou Extension 3 Filed
Oct 21, 2021
Teas Extension Received
Apr 30, 2021
Notice Of Approval Of Extension Request E-Mailed
Apr 28, 2021
Sou Extension 2 Granted
Apr 28, 2021
Sou Extension 2 Filed
Apr 28, 2021
Teas Extension Received
Oct 30, 2020
Notice Of Approval Of Extension Request E-Mailed
Oct 28, 2020
Sou Extension 1 Granted
Oct 28, 2020
Sou Extension 1 Filed
Oct 28, 2020
Teas Extension Received
Apr 28, 2020
Noa E-Mailed - Sou Required From Applicant
Mar 3, 2020
Official Gazette Publication Confirmation E-Mailed
Mar 3, 2020
Published For Opposition
Feb 12, 2020
Notification Of Notice Of Publication E-Mailed
Jan 27, 2020
Assigned To Lie
Jan 24, 2020
Approved For Pub - Principal Register
Jan 16, 2020
Teas/Email Correspondence Entered
Jan 15, 2020
Correspondence Received In Law Office
Jan 15, 2020
Teas Response To Office Action Received
Jul 16, 2019
Notification Of Non-Final Action E-Mailed
Jul 16, 2019
Non-Final Action E-Mailed
Jul 16, 2019
Non-Final Action Written
Jul 8, 2019
Assigned To Examiner
May 10, 2019
New Application Office Supplied Data Entered
Apr 29, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
